Tzeng CW - Search Results

1

Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.

Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JP. Tzeng CW, et al. Ann Surg Oncol. 2007 Jul;14(7):2150-8. doi: 10.1245/s10434-007-9409-5. Epub 2007 Apr 24. Ann Surg Oncol. 2007. PMID: 17453292

2

Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.

Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Buchsbaum DJ, Vickers SM, Heslin MJ, Arnoletti JP. Tzeng CW, et al. Surgery. 2007 Apr;141(4):464-9. doi: 10.1016/j.surg.2006.09.009. Epub 2007 Jan 22. Surgery. 2007. PMID: 17383523

3

ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.

Frolov A, Schuller K, Tzeng CW, Cannon EE, Ku BC, Howard JH, Vickers SM, Heslin MJ, Buchsbaum DJ, Arnoletti JP. Frolov A, et al. Among authors: tzeng cw. Cancer Biol Ther. 2007 Apr;6(4):548-54. doi: 10.4161/cbt.6.4.3849. Cancer Biol Ther. 2007. PMID: 17457047

4

EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.

Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JP. Tzeng CW, et al. J Surg Res. 2007 Nov;143(1):20-6. doi: 10.1016/j.jss.2007.01.051. J Surg Res. 2007. PMID: 17950068

5

Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.

Frolov A, Liles JS, Kossenkov AV, Tzeng CW, Jhala N, Kulesza P, Varadarajulu S, Eloubeidi M, Heslin MJ, Arnoletti JP. Frolov A, et al. Among authors: tzeng cw. Am J Surg. 2010 Sep;200(3):398-405. doi: 10.1016/j.amjsurg.2009.10.014. Epub 2010 Apr 21. Am J Surg. 2010. PMID: 20409526 Free PMC article.

6

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma.

Liles JS, Arnoletti JP, Tzeng CW, Howard JH, Kossenkov AV, Kulesza P, Heslin MJ, Frolov A. Liles JS, et al. Among authors: tzeng cw. Cancer Biol Ther. 2010 Sep 15;10(6):555-63. doi: 10.4161/cbt.10.6.12532. Epub 2010 Sep 30. Cancer Biol Ther. 2010. PMID: 20647770 Free PMC article.

7

Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.

Tzeng CW, Fiveash JB, Popple RA, Arnoletti JP, Russo SM, Urist MM, Bland KI, Heslin MJ. Tzeng CW, et al. Cancer. 2006 Jul 15;107(2):371-9. doi: 10.1002/cncr.22005. Cancer. 2006. PMID: 16752414 Free article. Clinical Trial.

8

Soft tissue sarcoma: preoperative and postoperative imaging for staging.

Tzeng CW, Smith JK, Heslin MJ. Tzeng CW, et al. Surg Oncol Clin N Am. 2007 Apr;16(2):389-402. doi: 10.1016/j.soc.2007.03.006. Surg Oncol Clin N Am. 2007. PMID: 17560519 Review.

9

Radiofrequency ablation for unresectable tumors of the liver.

Howard JH, Tzeng CW, Smith JK, Eckhoff DE, Bynon JS, Wang T, Arnoletti JP, Heslin MJ. Howard JH, et al. Among authors: tzeng cw. Am Surg. 2008 Jul;74(7):594-600; discussion 600-1. Am Surg. 2008. PMID: 18646476

10

Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer.

Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin A, Heslin M, Bellacosa A, Arnoletti JP. Howard JH, et al. Among authors: tzeng cw. Cancer Biol Ther. 2009 Jan;8(1):94-100. doi: 10.4161/cbt.8.1.7469. Epub 2009 Jan 20. Cancer Biol Ther. 2009. PMID: 19127118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page